← Leaderboards
Ralph Salloum
Research Inst Nationwide Children'S Hosp
$635,366
Attributed
$1,270,731
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $784.8K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
FDA$1,270,731 · 1
By mechanism
R01$1,270,731 · 1
Top collaborators
- Margot Lazow2 shared
Grant awards (2)
Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]$485,894
R01 · FY2024 · FD
Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]$784,837
R01 · FY2022 · FD